. 2016 Jan 22;7(8):9041–9045. doi: 10.18632/oncotarget.6984

Table 1. Approved drugs and source data used in the analysis.

Drug	Indication	Comparator	Trial name	Source data
Bortezomib	Multiple myeloma	Dexamethasone	APEX	Richardson, 2007^9,10
Sunitinib	Metastatic Renal-Cell Carcinoma	Interferon alpha	-	Motzer, 2007¹¹
Regorafenib	Metastatic colorectal cancer	Placebo	CORRECT	Grothey, 2012¹²
Sorafenib	Advanced Hepatocellular Carcinoma	Placebo	SHARP	Llovet, 2008¹³
Erlotinib	Advanced non-small-cell lung cancer	Placebo	SATURN	Coudert, 2012¹⁴